Cresco Labs to Become the New Leader in Cannabis with the Acquisition of Columbia Care
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (Cresco Labs or the Company) and Columbia Care Inc. (NEO:CCHW) (CSE:CCHW) (OTCQX:CCHWF) (Columbia Care) announced today they have entered into a definitive arrangement agreement (the Arrangement Agreement) pursuant to which Cresco Labs will acquire all of the issued and outstanding shares (the Columbia Care Shares) of Columbia Care (the Transaction).
- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (Cresco Labs or the Company) and Columbia Care Inc. (NEO:CCHW) (CSE:CCHW) (OTCQX:CCHWF) (Columbia Care) announced today they have entered into a definitive arrangement agreement (the Arrangement Agreement) pursuant to which Cresco Labs will acquire all of the issued and outstanding shares (the Columbia Care Shares) of Columbia Care (the Transaction).
- The Transaction provides Columbia Care Shareholders with premiums per Columbia Care Share of approximately 16% based on the closing prices of the Columbia Care Shares and the Cresco Labs Shares, and (ii) 19%, based on the 20-day volume weighted average prices (VWAP) of the Columbia Care Shares and the Cresco Labs Shares, each on the CSE as of March 22, 2022.
- The combination of Cresco Labs and Columbia Care accelerates our journey to become the leader in cannabis in a way no other potential transaction could.
- The Columbia Care Board unanimously recommends that Columbia Care Shareholders vote in favor of the resolution to approve the Transaction.